All News

Found 574 articles

• YM BioSciences Reports First Patient In Phase I/Ii Trial Of Jak1/Jak2 Inhibitor, Cyt387 Enrolled By Cytopia Limited

  11/24/2009

• YM BioSciences Announces $14.05 Million Offer for Cytopia Limited, an Australian Cancer-Focused Development Company

  10/6/2009

• Cytopia Limited Lodges IND for JAK2 Inhibitor CYT387

  6/23/2009

• Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays

  5/4/2009

• Cytopia Limited Scientific Presentations on JAK2 Inhibitor Program

  10/16/2008

• Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies

  8/20/2008

• Follica Announces $11M in New Financing and Expanded Team

  8/12/2008

• Cytopia Limited Appoints Study Chairman for JAK2 Clinical Trial

  7/29/2008

• Ipsogen Accelerates its Development in Europe with the CE Marking of its JAK2 Diagnostic Kits

  6/30/2008

• Cytopia Limited JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients Mayo Clinic in Key Role in Treatment Discovery

  1/30/2008

• Exelixis, Inc. Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2

  12/10/2007

• DelSite Biotechnologies, Inc. and ElSohly Laboratories Sign Amendment to Technology License Agreement

  9/26/2007

• Carrington Laboratories, Inc. and DaySpring Pharma Sign Term Sheet for Distribution of Diabetic and Radiation Products Into Physician Market

  8/17/2007

• Exelixis, Inc. Files IND Application for XL019, a Novel Anticancer Compound Targeting the JAK/STAT Signaling Pathway

  5/24/2007

• Carrington Laboratories, Inc. and Primus Pharmaceuticals, Inc. Sign Long-Term Supply and Patent Licensing Agreements for Acemannan Hydrogel(TM)

  4/19/2007

• DelSite Biotechnologies, Inc. Granted Growth Factor Stabilizer Patent By Korean Patent Office

  3/29/2007

• Zentiva Enters the Hungarian Market

  3/1/2007

• Carrington Laboratories, Inc. Subsidiary DelSite Biotechnologies, Inc. Signs Technology License Agreement With ElSohly Laboratories

  2/20/2007

• Carrington Laboratories, Inc. Subsidiary DelSite Biotechnologies, Inc. Signs Technology License Agreement With ElSohly Laboratories

  2/19/2007

• DelSite Biotechnologies, Inc. Granted Korean Patent For GelSite(R) Polymer Technology

  2/13/2007